Product: BSI CTMS | Industry: Life Science
BSI has replaced the existing system for the planning and management of clinical trials with BSI CTMS at ALK-Abelló, the specialist for allergy therapy with headquarters in Hørsholm, Denmark. The system depicts the complete trial process of this globally active manufacturer of allergy vaccines, down to the level of individual patients.
„This means that we are not only using existing resources more effectively, but also future resources. Status reports of trials can be generated at any time, providing us with reproducibility in trials, which in turn helps support us when working with trial partners and authorities.“
Martin Rud Pedersen
Around about 100 users worldwide receive online access to necessary standard forms, reports and statistics. Furthermore, BSI CTMS supports the research team in the planning and conducting of monitor visits. The company management receives a transparent view of the status and progress of the individual trials.